Hernandez-Albujar et al., "Idiopathic
esophageal ulcer with fistulization to the bronchial tree in a HIV-positive patient," Revista Espanola de Enfermedades Digestivas, vol.
Based on previous studies, we predicted that BHSST, containing these bioactive herbs as constituents, would enhance ameliorating effects on
esophageal ulcer induced chronic acid reflux esophagitis.
Diagnosis of
esophageal ulcers in acquired immunodeficiency syndrome.
The use of drugs to treat such conditions as esophageal reflux "heartburn" , hiatus hernia, esophagitis and
esophageal ulcer, and swallowing difficulties--as well as the enormous popularity of antiulcer medications--has led to the hypothesis that these drugs may be a causative factor.
Molecular mechanisms of epithelial regeneration and neovascularization during healing of gastric and
esophageal ulcers. Current Medicinal Chemistry, 19: 1627.
Patients with HIV may develop one or more giant
esophageal ulcers that are caused directly by the HIV virus itself, as confirmed on electron microscopy of biopsy specimens showing viral particles with morphologic features of HIV.
*
Esophageal ulcers: These are crater-like sores in the lining of the esophagus, which can bleed and may sometimes cause anemia (low red blood cell counts).
(1) The agent's manufacturer also warns that alendronate can cause upper gastrointestinal irritation that can lead to esophagitis,
esophageal ulcers, and esophageal erosions with bleeding; in rare cases, esophageal stricture or perforation may occur.
Idiopathic
esophageal ulcers, also known as chronic HIV-associated esophageal ulcerations, is a diagnosis of exclusion and usually occur in patients with CD4 cell counts less than 100/[micro]L.
These include nausea and heartburn,
esophageal ulcers, diarrhea, constipation, dizziness, headaches, and more frequent (and possibly painful) urination.
After three months, three percent of patients on famotidine and 15 percent of those on placebo had stomach ulcers; half of one percent of patients on famotidine and 17 percent of those on placebo had gastrointestinal ulcers; and four percent of patients on famotidine and 19 percent on placebo had
esophageal ulcers.